The decision by OxyContin maker Purdue Pharma to stop encouraging physicians to write prescriptions for the painkiller is drawing positive reviews from those fighting the nation's growing opioid epidemic. But a Longview pharmacist warns it could lead to higher costs and other inconveniences for ...
Longview druggist: Flaws in OxyContin marketing shift
- Written by: Norris Garman
- Category: Drug News
- Hits: 852